Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eldecalcitol vs alendronate on fall-related physical performance in frail Japanese women with osteoporosis
jRCT1080221967Phase 4Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of eldecalcitol in osteoporosis (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoint: Change in adjusted composite equilibrium score (CES) of sensory organization test (SOT). Started Nov 2012; status: completed.
02
Drugs
eldecalcitol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on jRCT1080221967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221967.